The journal of family planning and reproductive health care

J Fam Plann Reprod Health Care · ISSN (print) 1471-1893 · 19 papers in corpus
nonrandomized-trial 2015
·PMID:26668848

BACKGROUND: Endometriosis is a chronic and progressive condition of women of reproductive age. It is strongly associated with significant impairment of sexual function. AIM: To objectively evaluate the impact of laparoscopic excision of en…

nonrandomized-trial 2015
doi:10.1136/jfprhc-2014-100993 ·PMID:25883096

BACKGROUND: Endometriosis is a chronic and progressive condition of women of reproductive age. It is strongly associated with significant impairment of sexual function. AIM: To objectively evaluate the impact of laparoscopic excision of en…

other 2014
doi:10.1136/jfprhc-2014-100907 ·PMID:24648530

To bridge the gap – that’s what my brief for the Journal has always been. To create understanding between reproductive health professionals and health service consumers – to help the former appreciate the needs of the latter. This is why I …

review 2014
doi:10.1136/jfprhc-2013-100600 ·PMID:24648529

BACKGROUND: Extended use of the combined oral contraceptive pill (COC), defined as taking active pills for at least 28 days, has been used in order to avoid bleeding at important times and to treat gynaecological conditions such as endometr…

meta-analysis 2014
doi:10.1136/jfprhc-2013-100853 ·PMID:25183531

BACKGROUND: Endometriosis is experienced by approximately 10% of women worldwide; it is associated with significant burden on the woman, her family, and society. AIM: The aim of this systematic review was to synthesise the available qualit…

other 2013
doi:10.1136/jfprhc-2012-100530 ·PMID:24132514

It is a truth universally acknowledged that the main symptoms of endometriosis are pelvic pain and, to a lesser extent, infertility and fatigue.1 ,2 These symptoms affect an estimated 176 million women worldwide.3 What is less frequently a…

rct 2012
doi:10.1136/jfprhc-2011-100118 ·PMID:21933805

BACKGROUND: The aim of the study was to develop and validate measures of awareness of symptoms and risk factors for ovarian and cervical cancer (Ovarian and Cervical Cancer Awareness Measures). METHODS: Potentially relevant items were extr…

other 2012
doi:10.1136/jfprhc-2012-100345 ·PMID:22691698

More than 794 000 prescriptions are written for therapeutic (as opposed to contraceptive) use of norethisterone (or its synonym norethindrone) in the UK each year (data on file, Bayer plc). Although its licensed indications include “metropa…

other 2011
doi:10.1136/jfprhc-2011-0073 ·PMID:21727242
review 2010
doi:10.1783/147118910791069178 ·PMID:20406552

The discovery of the endometrial antiproliferative effect of PRMs was an important milestone in their development. It was also unexpected, as compounds on July 14,

observational 2010
doi:10.1783/147118910791749416 ·PMID:20659364

OBJECTIVE: The primary objective of the study was to clarify whether the use of the oral contraceptive 2 mg dienogest/30 microg ethinylestradiol (DNG/EE) is associated with a higher risk of venous thromboembolism (VTE) than the use of other…

case-report 2008
doi:10.1783/147118908786000325 ·PMID:18854081

Figure 1 Disposable vasectomy forceps used for Norplant ® removal ReplyWe thank Anne Bennett for her comments 1 related to our article describing removal techniques for contraceptive implants. 2any primary care organisations are bringing in…

qualitative 2007
doi:10.1783/147118907781004831 ·PMID:17609078

BACKGROUND AND METHODOLOGY: Endometriosis is a chronic condition in which endometrial glands and stroma are present outside of the uterus. Whereas chronic pelvic pain is the most commonly experienced pain of endometriosis, many women also s…

other 2007
doi:10.1783/147118907781004778 ·PMID:17609079

Endometriosis-associated dyspareunia/A better way of working Why was change needed?The National Health Service (NHS) is changing.New management structures and financial pressures have put sexual health services at risk.Commissioners are as …

case-report 2006
doi:10.1783/147118906776276143 ·PMID:16824305

The levonorgestrel-releasing intrauterine system (LNGIUS) Mirena has been licensed as a contraceptive in the UK since 1995. In 2002 Mirena became licensed also for the management of idiopathic menorrhagia and in 2004 the product licence was…

review 2005
doi:10.1783/1471189054483807 ·PMID:16105274
case-report 2005
doi:10.1783/0000000052972799 ·PMID:15720856

BACKGROUND: Endometriosis is one of the commonest benign gynaecological disorders and has a peak incidence between 30 and 45 years of age. Treatment options are medical or surgical, depending on the location and extent of the disease and th…

review 2003
doi:10.1783/147118903101197188 ·PMID:12626173

OBJECTIVE: To review the literature on the most recent progestogens to be developed, to provide clinical comparisons with older progestogens and to look at the potential of products not yet marketed. DATA SOURCES: Searches of Medline and P…

review 2002
doi:10.1783/147118902101196063 ·PMID:12396783

OBJECTIVE: To review the literature on usage of the levonorgestrel intrauterine system (LNG IUS) in women with fibroids or adenomyosis in an attempt to develop a pragmatic approach when faced with enlarged uteri. DATA SOURCES: Computerised…